83. Addison disease Clinical trials / Disease details
Clinical trials : 20 / Drugs : 39 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 18
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004313 (ClinicalTrials.gov) | August 1995 | 18/10/1999 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency | Addison's Disease | Drug: dehydroepiandrosterone | National Center for Research Resources (NCRR) | University of California, Los Angeles | Completed | 18 Years | N/A | Both | 40 | Phase 3 | NULL |